Jeff Nicoson

Jeff Nicoson has a strong background in the pharmaceutical industry, with significant experience in analytical development and process chemistry roles. Jeff started their career at Endocyte in 2003 as an Analytical Scientist I and progressed to roles of increasing responsibility, including Associate Director and Director positions. At Endocyte, Jeff led teams in analytical and process chemistry, contributing to the development of pharmaceutical products. Jeff then moved on to Advanced Accelerator Applications in 2022, where they served as the Head of QC and AS&T. Most recently, Jeff joined Nucleus Radiopharma in 2023 as the Vice President of Product Development. Overall, Jeff Nicoson has demonstrated expertise in analytical development, process chemistry, and leadership roles within the pharmaceutical industry.

Jeff Nicoson earned a Bachelor's degree in Chemistry from Wabash College, where they studied from 1993 to 1997. Jeff then went on to pursue a Doctor of Philosophy (PhD) in Analytical Chemistry at Purdue University from 1998 to 2003.